These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25831456)

  • 1. Platelet Count After Chemotherapy is a Predictor for Outcome for Ovarian Cancer Patients.
    Eggemann H; Ehricke J; Ignatov T; Fettke F; Semczuk A; Costa SD; Ignatov A
    Cancer Invest; 2015 May; 33(5):193-6. PubMed ID: 25831456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytosis and anaemia in women with recurrent ovarian cancer prior to a second-line chemotherapy.
    Nather A; Mayerhofer K; Grimm C; Hefler L; Leodolter S; Obermair A; Joura EA
    Anticancer Res; 2003; 23(3C):2991-4. PubMed ID: 12926151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T; Renninger M; Schwentner C; Stenzl A; Gakis G
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of thrombocytosis in ovarian cancer.
    Słabuszewska-Jóźwiak A; Dmoch-Gajzlerska E; Kozakiewicz B; Jakiel G
    Ann Agric Environ Med; 2015; 22(4):731-5. PubMed ID: 26706987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of platelet count with second-look laparotomy results and disease progression in patients with advanced epithelial ovarian cancer.
    Bozkurt N; Yuce K; Basaran M; Kose F; Ayhan A
    Obstet Gynecol; 2004 Jan; 103(1):82-5. PubMed ID: 14704249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer.
    Hu Q; Hada A; Han L
    J Ovarian Res; 2020 Jul; 13(1):78. PubMed ID: 32682445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: a population-based study.
    van Altena AM; Kolwijck E; Spanjer MJ; Hendriks JC; Massuger LF; de Hullu JA
    Gynecol Oncol; 2010 Nov; 119(2):265-9. PubMed ID: 20797777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation between platelet count and CA-125 in ovarian cancer].
    Friebe Z; Watrowski R; Bembnista M; Rokowska A; Włosiińska J; Dembińska M
    Ginekol Pol; 2005 Mar; 76(3):187-94. PubMed ID: 16018136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential platelet levels affect response to taxane-based therapy in ovarian cancer.
    Bottsford-Miller J; Choi HJ; Dalton HJ; Stone RL; Cho MS; Haemmerle M; Nick AM; Pradeep S; Zand B; Previs RA; Pecot CV; Crane EK; Hu W; Lutgendorf SK; Afshar-Kharghan V; Sood AK
    Clin Cancer Res; 2015 Feb; 21(3):602-10. PubMed ID: 25473001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
    Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis as a prognostic factor in endometrial carcinoma.
    Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
    Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group Study.
    Schilder RJ; Sill MW; Lee RB; Shaw TJ; Senterman MK; Klein-Szanto AJ; Miner Z; Vanderhyden BC
    J Clin Oncol; 2008 Jul; 26(20):3418-25. PubMed ID: 18612157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis in advanced epithelial ovarian cancer.
    Soonthornthum T; Suraseraneewong V; Kengsakol K; Wijaithum K; Kasemsan P; Prommatt S
    J Med Assoc Thai; 2007 Aug; 90(8):1495-500. PubMed ID: 17926975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
    Lin MS; Huang JX; Zhu J; Shen HZ
    Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of platelet and fibrinogen on progressive ovarian cancer].
    Li CY; Wu M; Yuan JY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):81-3. PubMed ID: 19317067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative elevated platelet count and thrombocytosis in gynecologic malignancies.
    Menczer J
    Arch Gynecol Obstet; 2017 Jan; 295(1):9-15. PubMed ID: 27714462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
    Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
    Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombocytosis as a predictor of distant recurrence in patients with rectal cancer.
    Cravioto-Villanueva A; Luna-Perez P; Gutierrez-de la Barrera M; Martinez-Gómez H; Maffuz A; Rojas-Garcia P; Perez-Alvarez C; Rodriguez-Ramirez S; Rodriguez-Antezana E; Ramirez-Ramirez L
    Arch Med Res; 2012 May; 43(4):305-11. PubMed ID: 22727694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony-stimulating factor enhances platelet recovery following cisplatin/carboplatin chemotherapy in ovarian cancer.
    Suzuki M; Ohwada M; Aida I; Sato I; Tamada T
    Gynecol Oncol; 1994 Jul; 54(1):23-6. PubMed ID: 8020834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records.
    Cozzi GD; Samuel JM; Fromal JT; Keene S; Crispens MA; Khabele D; Beeghly-Fadiel A
    BMC Cancer; 2016 Aug; 16():612. PubMed ID: 27502272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.